James Mullins
Defined Benefit
Demand for buy-ins is set to triple over the next decade as more defined benefit (DB) schemes look to offload their liabilities to insurers.
24 August 2016
•
2 min read
Risk Reduction
The cost of longevity risk for defined benefit (DB) schemes has increased by 50% in the past 12 years due to falling long-term interest rates.
11 July 2016
•
2 min read
Defined Benefit
Aegon has sold a £6bn UK annuity portfolio to Rothesay Life in a bid to focus on expanding its investment platform.
11 April 2016
•
1 min read
Bulk Annuities
As medically underwritten deals reach record levels, PP looks at why this market is booming.
25 January 2016
•
4 min read
Risk Reduction
The £150m Institution of Engineering and Technology ("IET") Superannuation and Assurance Scheme has completed a £32m medically underwritten buy-in.
17 December 2015
•
Risk Reduction
The impact of Solvency II on bulk annuity pricing will be limited, but schemes with generous options could see hefty increases, finds Jack Jones
09 December 2015
•
Risk Reduction
The market for enhanced bulk annuities has almost hit £700m after a bumper fourth quarter in which 10% of all transactions was medically underwritten, according to research from Hymans Robertson.
23 February 2015
•
Risk Reduction
Pension fund trustees are increasingly responsible for managing risk, but lack the skills to do, according to research by a pension consultancy.
03 September 2014
•
Risk Reduction
Buy-in prices have fallen by up to 3% as a result of changes announced in last month's Budget, one consultant says.
17 April 2014
•
